Nido Biosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2018-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://nidobio.com
Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study of NIDO-361 in Patients With SBMA
Phase 2
Active, not recruiting
- Conditions
- Spinal and Bulbar Muscular AtrophyKennedy's Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-05-13
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Nido Biosciences, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT06411912
- Locations
- 🇩🇰
Rigshospitalet, Klinik for Nerve- og Muskelsygdomme & Copenhagen Neuromuscular Center, Copenhagen, Denmark
🇮🇹IRCCS Istituto Neurologico Carlo Besta, Milano, Italy
🇮🇹Azienda Ospedale Università di Padova, Padova, Italy
News
No news found